Unaudited Condensed Consolidated Statements of Stockholders’ Equity - USD ($)	Common Stock	Additional Paid in Capital	Accumulated Other Comprehensive Loss	Accumulated Deficit	Total
Balance at Dec. 31, 2022	$ 1,448	$ 120,105,728	$ (139,295)	$ (97,088,422)	$ 22,879,459
Balance (in Shares) at Dec. 31, 2022	1,447,722
Stock-based compensation		751,821			751,821
Costs related to ATM		(17,920)			(17,920)
Foreign currency translation adjustment			(18,669)		(18,669)
Net loss				(7,051,367)	(7,051,367)
Balance at Mar. 31, 2023	$ 1,448	120,839,629	(157,964)	(104,139,789)	16,543,324
Balance (in Shares) at Mar. 31, 2023	1,447,722
Balance at Dec. 31, 2022	$ 1,448	120,105,728	(139,295)	(97,088,422)	22,879,459
Balance (in Shares) at Dec. 31, 2022	1,447,722
Net loss					(16,480,817)
Balance at Sep. 30, 2023	$ 2,365	127,461,515	(203,712)	(113,569,239)	13,690,929
Balance (in Shares) at Sep. 30, 2023	2,365,342
Balance at Mar. 31, 2023	$ 1,448	120,839,629	(157,964)	(104,139,789)	16,543,324
Balance (in Shares) at Mar. 31, 2023	1,447,722
Stock-based compensation		825,719			825,719
Costs related to ATM		(59,229)			(59,229)
Foreign currency translation adjustment			(7,566)		(7,566)
Net loss				(5,020,206)	(5,020,206)
Balance at Jun. 30, 2023	$ 1,448	121,606,119	(165,530)	(109,159,995)	12,282,042
Balance (in Shares) at Jun. 30, 2023	1,447,722
Sales of common stock through the at-the-market offering	$ 2	25,270			25,272
Sales of common stock through the at-the-market offering (in Shares)	2,404
Sale of common stock and warrants through public offering, net of offering costs	$ 915	5,063,807			5,064,722
Sale of common stock and warrants through public offering, net of offering costs (in Shares)	915,216
Stock-based compensation		766,319			766,319
Foreign currency translation adjustment			(38,182)		(38,182)
Net loss				(4,409,244)	(4,409,244)
Balance at Sep. 30, 2023	$ 2,365	127,461,515	(203,712)	(113,569,239)	13,690,929
Balance (in Shares) at Sep. 30, 2023	2,365,342
Balance at Dec. 31, 2023	$ 2,370	128,044,509	(148,192)	(118,331,653)	$ 9,567,034
Balance (in Shares) at Dec. 31, 2023	2,370,000				2,370,000
Sales of common stock through the at-the-market offering	$ 2	12,582			$ 12,584
Sales of common stock through the at-the-market offering (in Shares)	1,720
Sale of common stock and warrants through public offering, net of offering costs	$ 147	903,408			903,555
Sale of common stock and warrants through public offering, net of offering costs (in Shares)	147,500
Stock-based compensation		626,990			626,990
Costs related to ATM		(15,000)			(15,000)
Foreign currency translation adjustment			(55,595)		(55,595)
Net loss				(5,735,144)	(5,735,144)
Balance at Mar. 31, 2024	$ 2,519	129,572,489	(203,787)	(124,066,797)	5,304,424
Balance (in Shares) at Mar. 31, 2024	2,519,220
Balance at Dec. 31, 2023	$ 2,370	128,044,509	(148,192)	(118,331,653)	$ 9,567,034
Balance (in Shares) at Dec. 31, 2023	2,370,000				2,370,000
Net loss					$ (13,759,298)
Balance at Sep. 30, 2024	$ 3,538	135,391,296	(166,647)	(132,090,951)	$ 3,137,236
Balance (in Shares) at Sep. 30, 2024	3,538,248				3,538,248
Balance at Mar. 31, 2024	$ 2,519	129,572,489	(203,787)	(124,066,797)	$ 5,304,424
Balance (in Shares) at Mar. 31, 2024	2,519,220
Sales of common stock through the at-the-market offering	$ 148	293,354			293,502
Sales of common stock through the at-the-market offering (in Shares)	147,476
Sale of common stock and warrants through public offering, net of offering costs	$ 579	4,198,385			4,198,964
Sale of common stock and warrants through public offering, net of offering costs (in Shares)	578,914
Stock-based compensation		608,352			608,352
Costs related to ATM		(67,729)			(67,729)
Foreign currency translation adjustment			19,024		19,024
Net loss				(4,479,221)	(4,479,221)
Balance at Jun. 30, 2024	$ 3,246	134,604,851	(184,763)	(128,546,018)	5,877,316
Balance (in Shares) at Jun. 30, 2024	3,245,610
Sales of common stock through the at-the-market offering	$ 102	220,679			220,781
Sales of common stock through the at-the-market offering (in Shares)	102,333
Issuance of common stock for warrant exercises	$ 190	(171)			19
Issuance of common stock for warrant exercises (in Shares)	190,305
Stock-based compensation		567,672			567,672
Costs related to ATM		(1,735)			(1,735)
Foreign currency translation adjustment			18,116		18,116
Net loss				(3,544,933)	(3,544,933)
Balance at Sep. 30, 2024	$ 3,538	$ 135,391,296	$ (166,647)	$ (132,090,951)	$ 3,137,236
Balance (in Shares) at Sep. 30, 2024	3,538,248				3,538,248